Shareholders Approve Highly Dilutive Issuance of 8.5M Shares for Forekast Limited Acquisition

summarizeSummary

Greenpro Capital Corp. shareholders have formally approved the issuance of 8.5 million new shares for an acquisition, leading to significant dilution for current investors.

check_boxKey Events · Financing and Capital Events · GRNQ

• Shareholder Approval for Share Exchange

  Majority stockholders formally approved the Share Exchange Agreement and the issuance of 8,500,000 shares of Common Stock to acquire a 13.6% interest in Forekast Limited.

• Significant Dilution Confirmed

  The issuance of 8.5 million new shares will represent approximately 49.63% of the company's total outstanding equity post-transaction, causing substantial dilution to existing shareholders.

• Strategic Rationale for Acquisition

  The company believes Forekast's AI-driven platforms will create synergy with Greenpro's financial advisory and digital asset ecosystem, aiming for an end-to-end digital finance and AI solutions platform.

• Nasdaq Compliance Requirement Met

  Stockholder approval was sought and obtained to comply with Nasdaq Listing Rule 5635(a) and potentially 5635(d), as the issuance exceeds 20% of the company's pre-transaction outstanding stock.

auto_awesomeAnalysis · GRNQ · Trade & Services

Greenpro Capital Corp. has received definitive shareholder approval for the issuance of 8.5 million new common shares to acquire a 13.6% stake in Forekast Limited. This issuance represents approximately 49.63% of the company's post-transaction outstanding equity, resulting in substantial dilution for existing shareholders. While the company cites strategic benefits from Forekast's AI platforms, the immediate impact is a significant reduction in existing shareholder ownership. This formal approval follows the initial announcement of the share exchange agreement on February 17, 2026, and is a critical step for the transaction to proceed and ensure compliance with Nasdaq listing rules.